GALLERI, PAOLO
GALLERI, PAOLO
MEDICINA, CHIRURGIA E FARMACIA
18F-FDG brain and whole body (WB) PET/CT in intracranial leptomeningeal carcinomatosis and in paraneoplastic neurologic syndromes
2022-01-01 Galleri, P.; Lazzarato, A.; Sanna, C.; Mura, A.; Marongiu, A.; Frantellizzi, V.; De Vincentis, G.; Spanu, A.; Madeddu, G.
18F-FDG PET/CT in patients with autoimmune encephalitis in the early stage.
2024-01-01 Marongiu, Andrea; Galleri, Paolo; Papaleo, Antonio; Mura, Antonio; Madeddu, Giuseppe; Spanu, Angela; Solla, Paolo; Nuvoli, Susanna.
Brain 123I-ioflupane SPECT and 18F-FDG PET combined use in movement and cognitive associated diseases of recent appearance
2022-01-01 Lazzarato, A.; Sanna, C.; Galleri, P.; Marongiu, A.; Frantellizzi, V.; De Vincentis, G.; Spanu, A.; Madeddu, G.; Nuvoli, S.
Brain 18F-FDG PET/CT usefulness in primary progressive aphasia variant diagnosis and in their development into Alzheimer’s disease or fronto-temporal dementia
2022-01-01 Sanna, C.; Lazzarato, A.; Galleri, P.; Marongiu, A.; Mura, A.; Filippi, L.; Palumbo, B.; Spanu, A.; Madeddu, G.; Nuvoli, S.
Brain SPECT DAT imaging and 18F-FDG PET/CT combined use in the early stage of movement and cognitive associated neurodegenerative disorders
2024-01-01 Marongiu, A.; Galleri, P.; Sanna, C.; Fadda, C.; Di Bella, M.; Medde, E.; Vargiu, S.; Filippi, L.; Palumbo, B.; Spanu, A.; Madeddu, G.; Nuvoli., S.
Cortical metabolic 18F-FDG PET assessment and striatal dopamine transporter SPECT imaging in suspected early neurodegenerative disorders with uncertain movement and cognitive symptoms
2022-01-01 Nuvoli, S.; Lazzarato, A.; Carlo, S.; Galleri, P.; Marongiu, A.; Filippi, L.; Palumbo, B.; Spanu, A.; Madeddu, G.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 18F-FDG brain and whole body (WB) PET/CT in intracranial leptomeningeal carcinomatosis and in paraneoplastic neurologic syndromes | 1-gen-2022 | Galleri, P.; Lazzarato, A.; Sanna, C.; Mura, A.; Marongiu, A.; Frantellizzi, V.; De Vincentis, G.; Spanu, A.; Madeddu, G. | |
| 18F-FDG PET/CT in patients with autoimmune encephalitis in the early stage. | 1-gen-2024 | Marongiu, Andrea; Galleri, Paolo; Papaleo, Antonio; Mura, Antonio; Madeddu, Giuseppe; Spanu, Angela; Solla, Paolo; Nuvoli, Susanna. | |
| Brain 123I-ioflupane SPECT and 18F-FDG PET combined use in movement and cognitive associated diseases of recent appearance | 1-gen-2022 | Lazzarato, A.; Sanna, C.; Galleri, P.; Marongiu, A.; Frantellizzi, V.; De Vincentis, G.; Spanu, A.; Madeddu, G.; Nuvoli, S. | |
| Brain 18F-FDG PET/CT usefulness in primary progressive aphasia variant diagnosis and in their development into Alzheimer’s disease or fronto-temporal dementia | 1-gen-2022 | Sanna, C.; Lazzarato, A.; Galleri, P.; Marongiu, A.; Mura, A.; Filippi, L.; Palumbo, B.; Spanu, A.; Madeddu, G.; Nuvoli, S. | |
| Brain SPECT DAT imaging and 18F-FDG PET/CT combined use in the early stage of movement and cognitive associated neurodegenerative disorders | 1-gen-2024 | Marongiu, A.; Galleri, P.; Sanna, C.; Fadda, C.; Di Bella, M.; Medde, E.; Vargiu, S.; Filippi, L.; Palumbo, B.; Spanu, A.; Madeddu, G.; Nuvoli., S. | |
| Cortical metabolic 18F-FDG PET assessment and striatal dopamine transporter SPECT imaging in suspected early neurodegenerative disorders with uncertain movement and cognitive symptoms | 1-gen-2022 | Nuvoli, S.; Lazzarato, A.; Carlo, S.; Galleri, P.; Marongiu, A.; Filippi, L.; Palumbo, B.; Spanu, A.; Madeddu, G. |